3185 results for «3512»
3185 results
Getting ready for tricuspid TEER: key steps in building a successful programme
14 Feb 2026 – From PCR Tokyo Valves 2026
Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.
Patient selection for tricuspid TEER in 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on optimizing patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. It integrates anatomical, haemodynamic, and clinical criteria to identify ideal candidates, explores evolving treatment boundaries between TEER, transcatheter tricuspid valve replacement (TTVR), and medical management, and applies evidence from key trials...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...
TAVI: new evidence and clinical trials
14 Feb 2026 – From PCR Tokyo Valves 2026
This session reviews the latest evidence from head-to-head clinical trials comparing contemporary TAVI devices, including detailed discussions of the LANDMARK and COMPARE trials. It also highlights ongoing and upcoming clinical trials poised to influence guideline recommendations and expand the therapeutic scope of TAVI, providing crucial insights...
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the multidisciplinary team approach to managing structural heart disease, focusing on responses to unexpected intraoperative and postoperative situations. It features real-world experiences from a TAVI radiologic technologist, clinical engineer, TEER sonographer, and TEER nurse, emphasizing their respective roles in addressing intraoperative events, sudden...
Transcatheter electrosurgery and leaflet modification of the aortic valve
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...
Mechanical circulatory support protected PCI in complex calcified patients
28 Feb 2026 – From Euro4C Annual Meeting 2026
Explore the critical role of mechanical circulatory support with Impella in complex calcified patients undergoing PCI. This session delves into patient selection criteria, reviews the latest evidence, and discusses strategies to prevent and manage device-related complications, supported by case presentations focusing on imaging analysis, vascular access...
Plaque modification in different lesions types: nodular, long lesions, tortuous lesions, bifurcations
28 Feb 2026 – From Euro4C Annual Meeting 2026
Explore advanced plaque modification strategies tailored to diverse lesion types such as nodular, long, tortuous lesions, and bifurcations. Delve into approaches for managing under-expanded stents and calcified nodules, supported by evidence including results from the French orbital atherectomy registry.
How to avoid and manage complications
28 Feb 2026 – From Euro4C Annual Meeting 2026
Build a comprehensive complication-management toolbox tailored for PCI in heavily calcified vessels. This session covers prevention and management techniques for complications arising from severely calcified lesions, illustrated by practical cases and expert insights into risky lesions and challenging devices.
Drug-eluting balloon in calcified lesions and complex lesions
28 Feb 2026 – From Euro4C Annual Meeting 2026
This session explores the application of drug-eluting balloons (DCB) in managing calcified and complex coronary lesions. Emphasis is placed on identifying appropriate lesions for a DCB-only strategy, the critical role of vessel preparation prior to drug delivery, and the long-term physiological assessment following treatment, supported by...
It is a calcified left main: do it well, do it safely
28 Feb 2026 – From Euro4C Annual Meeting 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) in calcified left main coronary artery disease. It covers comprehensive planning including mechanical circulatory support, intravascular imaging, and bifurcation strategies. Attendees will also learn to anticipate and manage potential complications and apply various tools to ensure...
ResilCard - A resilience assessment tool to ensure cardiovascular care continuity during crises
28 Feb 2026 – From Euro4C Annual Meeting 2026
Introducing ResilCard, a novel resilience assessment tool designed to maintain continuity of cardiovascular care during crises. This session highlights the importance of preparedness and adaptive strategies to ensure uninterrupted patient management in challenging healthcare environments.
The best cases of the Euro4C PCRonline website
28 Feb 2026 – From Euro4C Annual Meeting 2026
This session presents some of the most instructive and challenging cases featured on the Euro4C PCRonline website. The cases encompass management of stalled rotational atherectomy burrs, combined use of intravascular lithotripsy and Impella in saphenous vein grafts, complexities of calcium in tortuous anatomy, and strategies for...
Closing Ceremony
28 Feb 2026 – From Euro4C Annual Meeting 2026
The closing ceremony marks the conclusion of the conference, providing a summary of key learnings, acknowledgments, and final reflections on the advancements and discussions presented throughout the event.
Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant
14 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...
From diagnosis to device: decision-making and planning for mitral valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers a structured approach to mitral TEER, integrating advanced imaging techniques for detailed mitral valve morphology evaluation, procedural planning, and complication prediction. It highlights device selection considerations and emerging technologies to tailor interventions for complex mitral valve disease, supported by multiple case presentations and...
Healthcare professionals in the structural heart disease treatment
15 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the essential roles and contributions of various healthcare professionals involved in structural heart disease treatment. It offers insights into the unique responsibilities of medical technologists, nurses, and radiological technologists across preoperative, intraoperative, and postoperative stages, fostering collaboration and sharing practical tips to strengthen...
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.
Contemporary approach in the treatment of calcified coronary artery disease
28 Feb 2026 – From Euro4C Annual Meeting 2026
Adopt a contemporary approach to managing calcified coronary artery disease by leveraging high-definition IVUS for lesion assessment and morphology evaluation. Learn to tailor calcium modification strategies based on IVUS findings and combine available tools to optimize treatment outcomes according to patient and lesion profiles.
Welcome to the Euro4C Annual Meeting 2026
27 Feb 2026 – From Euro4C Annual Meeting 2026
This introductory session sets the stage for a comprehensive exploration of interventional cardiology topics, providing attendees with an overview and framework for the upcoming educational content.
